Keros Therapeutics (KROS) Stock Chart & Stock Price History $13.51 -0.14 (-1.03%) Closing price 04:00 PM EasternExtended Trading$13.50 0.00 (-0.04%) As of 06:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Keros Therapeutics Stock Price Performance The Keros Therapeutics (KROS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 70.34%, with a year-to-date return of -14.66%. In the past month, the stock has decreased 7.28%, reflecting recent market activity. As of the latest close, Keros Therapeutics traded at $13.65 with a market cap of $554.46 million and volume of 360,018 shares. Five years ago, the stock traded at $40.39, representing a 66.55% decrease over that period. At the time, it had a market cap of $748.37 million and a volume of 150,300 shares. Receive KROS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.15%1 Month Performance-7.28%3 Month Performance+22.71%Year-To-Date Performance-14.66%1 Year Performance-70.34%5 Year Performance-66.55% KROS Stock Chart for Thursday, June, 26, 2025 KROS Chart by TradingView Keros Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/26/2025$13.65$13.51-1.03%$13.70$13.44344,728 shs$548.78 million06/25/2025$13.71$13.65-0.44%$13.81$13.41360,018 shs$554.46 million06/24/2025$13.76$13.71-0.36%$13.99$13.57284,882 shs$556.90 million06/23/2025$13.49$13.76+2.00%$13.77$13.42289,260 shs$558.86 million06/20/2025$13.55$13.49-0.44%$13.64$13.37657,126 shs$547.96 million06/19/2025$13.55$13.55$13.80$13.40294,204 shs$550.40 million06/18/2025$13.46$13.55+0.67%$13.80$13.40294,204 shs$550.33 million06/17/2025$13.66$13.46-1.46%$13.76$13.31298,557 shs$546.68 million06/16/2025$13.56$13.66+0.74%$13.91$13.50587,268 shs$554.80 million06/13/2025$13.64$13.56-0.59%$13.84$13.34377,905 shs$550.74 million Get the Latest News and Ratings for KROS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/12/2025$13.79$13.64-1.09%$14.00$13.54489,193 shs$553.99 million06/11/2025$13.75$13.79+0.29%$14.05$13.71428,821 shs$560.08 million06/10/2025$14.09$13.75-2.41%$14.02$13.501.35 million shs$558.46 million06/09/2025$15.04$14.09-6.32%$15.14$14.002.15 million shs$572.27 million06/06/2025$15.11$15.04-0.46%$15.40$14.93739,298 shs$610.85 million06/05/2025$14.82$15.11+1.96%$15.23$14.64512,421 shs$613.69 million06/04/2025$14.95$14.82-0.87%$15.17$14.76455,850 shs$601.91 million06/03/2025$14.66$14.95+1.98%$15.20$14.59666,017 shs$607.19 million06/02/2025$14.27$14.66+2.73%$14.79$14.15507,460 shs$595.42 million05/30/2025$14.02$14.27+1.78%$14.33$13.77480,221 shs$579.58 million05/29/2025$14.64$14.02-4.23%$14.54$13.81550,423 shs$569.42 million05/28/2025$14.35$14.64+2.02%$14.91$14.37447,245 shs$594.60 million05/27/2025$14.57$14.35-1.51%$14.69$14.17796,080 shs$582.83 million05/26/2025$14.57$14.57$14.74$14.01581,064 shs$591.76 million Related Companies Gemini Therapeutics Stock Price Chart Arrowhead Pharmaceuticals Stock Price Chart Twist Bioscience Stock Price Chart Vericel Stock Price Chart Recursion Pharmaceuticals Stock Price Chart Agios Pharmaceuticals Stock Price Chart Denali Therapeutics Stock Price Chart NewAmsterdam Pharma Stock Price Chart Sarepta Therapeutics Stock Price Chart Kiniksa Pharmaceuticals International Stock Price Chart Receive KROS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KROS) was last updated on 6/26/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredWhy July is critical for your stocksBig Study Shows Stocks Extremely Likely to Crash in 2026? Legendary quant analyst Marc Chaikin says in 50 y...Chaikin Analytics | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump: "Buy Stocks Now!" (Here's a Better Move)Trump: "Buy Stocks Now!" (Here's a Better Move) President Trump just announced from the Oval Office: "You b...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Keros Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Keros Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KROS Stock Free KROS Stock Alerts